BioMarin Pharmaceutical
BMRN
#1478
Rank
NZ$20.85 B
Marketcap
$109.42
Share price
-0.54%
Change (1 day)
-28.10%
Change (1 year)

Earnings for BioMarin Pharmaceutical (BMRN)

Earnings in 2024 (TTM): NZ$0.63 Billion

According to BioMarin Pharmaceutical's latest financial reports the company's current earnings are NZ$2.75 Billion. In 2023 the company made an earning of NZ$0.33 Billion, an increase over its 2022 earnings that were of NZ$0.26 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for BioMarin Pharmaceutical from 1999 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) NZ$0.63 B88.82%
2023 NZ$0.33 B26.07%
2022 NZ$0.26 B-298.51%
2021 -NZ$0.14 Billion78.04%
2020 -NZ$75.61 Million-55.36%
2019 -NZ$0.17 Billion-33.56%
2018 -NZ$0.26 Billion297.78%
2017 -NZ$64.1 Million-95.68%
2016 -NZ$1.49 Billion437.12%
2015 -NZ$0.28 Billion23.91%
2014 -NZ$0.23 Billion-29.25%
2013 -NZ$0.32 Billion49.23%
2012 -NZ$0.22 Billion171.11%
2011 -NZ$77.94 Million103.01%
2010 -NZ$38.4 Million-3903.54%
2009 NZ$1 M-98.31%
2008 NZ$59.71 M-189.7%
2007 -NZ$66.57 Million51.02%
2006 -NZ$44.09 Million-61.58%
2005 -NZ$0.12 Billion-56.59%
2004 -NZ$0.27 Billion95.13%
2003 -NZ$0.14 Billion12.09%
2002 -NZ$0.13 Billion73.19%
2001 -NZ$69.76 Million18.32%
2000 -NZ$58.96 Million19.65%
1999 -NZ$49.28 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-NZ$0.89 Billion-226.77%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$0.24 Billion-134.29%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$51.61 Million-107.38%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$13.23 B 1,792.41%๐Ÿ‡ซ๐Ÿ‡ท France
-NZ$0.13 Billion-117.46%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$0.33 B-51.77%๐Ÿ‡บ๐Ÿ‡ธ USA